Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET) - Concepedia

Concepedia

Publication | Open Access

Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)

DOI Full Paper Access

63

Citations

28

References

2019

Year

Asma Bashir, Sofie Mathilde Jacobsen, Otto Mølby Henriksen, Helle Broholm, Thomas Urup, Kirsten Grunnet, Vibeke Andrée Larsen, Søren Møller, Jane Skjøth‐Rasmussen, Hans Skovgaard Poulsen,

Abstract

A 20-minute 18F-FET PET scan is a powerful tool to distinguish posttreatment changes from recurrent glioblastoma 6-month postradiotherapy, and predicts OS.

References

	Year	Citations
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren Mason, Martin J. van den Bent, New England Journal of Medicine	2005	21K
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010 Quinn T. Ostrom, Haley Gittleman, P Farah, Neuro-Oncology	2013	12.1K
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Patrick Y. Wen, David R. Macdonald, David A. Reardon, Journal of Clinical Oncology EngineeringHigh-grade GliomasBrain LesionResponse AssessmentGlioma	2010	3.7K
DNA methylation-based classification of central nervous system tumours David Capper, David Jones, Martin Sill, Nature Neuro-oncologyDna Methylation-based ClassificationMedicineEpigenetic ChangeDna Methylation	2018	2.9K
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 Quinn T. Ostrom, Haley Gittleman, Jordonna Fulop, Neuro-Oncology	2015	2.1K
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma Brett Johnson, Tali Mazor, Chibo Hong, Science	2013	1.4K
Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors David Capper, Susanne Weißert, Antje Habel, Brain Pathology ImmunologyPathologyHigh-grade GliomasGliomaTumor Biology	2009	518
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 Ian Law, Nathalie L. Albert, Javier Arbizu, European Journal of Nuclear Medicine and Molecular Imaging	2018	516
Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma Gabriele P�pperl, Claudia G�tz, Walter Rachinger, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyRecurrent GliomaEngineeringOncologic ImagingGlioma	2004	287
Positron Emission Tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus Magnetic Resonance Imaging in the Diagnosis of Recurrent Gliomas Walter Rachinger, Claudia Goetz, Gabriele Pöpperl, Neurosurgery	2005	286

Page 1